Decatur Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Decatur Capital Management, Inc.
- $184 Million
- Q1 2024
A detailed history of Decatur Capital Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Decatur Capital Management, Inc. holds 2,605 shares of REGN stock, worth $2.69 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
2,605
Previous 2,630
0.95%
Holding current value
$2.69 Million
Previous $2.31 Million
8.58%
% of portfolio
1.36%
Previous 1.38%
Shares
6 transactions
Others Institutions Holding REGN
# of Institutions
1,427Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.24 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.86 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.99 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.01 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.81 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $111B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...